Jun 2026 (Q2 FY26) — Aug 7, 2026
Oklo Q2 FY26 — Groves Reactor Achieves Criticality, Accelerating Execution Capabilities
Read the full callOklo (OKLO) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Oklo earnings: last reported Fri, 7 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 1.2 | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. The year-earlier figure was zero or a loss, so no percentage is shown. | |
| Operating margin | -6048.8 | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. | |
| Net profit | -48.5 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$30.01 +3.34% · +$0.97
Performance −82.8% 1Y
1Y: $174.14 on 14 Oct 2025 → $30.01. High $174.14 (14 Oct 2025), low $29.04 (14 Oct 2026).
- Previous close
- $29.04
- 52-week range
- $29.04 – $174.14
- One year
- −82.51%
Overview
- Symbol
- OKLO
- Sector
- Utilities
- Exchange
- US
- Currency
- USD
Call summaries
Mar 2026 (Q1 FY26) — May 12, 2026
Oklo Q1 FY26 — Strategic Execution and Multi-Pathway Progress
Read the full callDec 2025 (Q4 FY25) — Mar 17, 2026
Oklo Q4 FY25 — Strategic Deployment and Strong Balance Sheet
Read the full callEvery analysed call
Oklo earnings calls (OKLO)
Financials
What the filings say
Net profit, year on year: −97% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | — | — | — | 0 | — | — | — | 1 |
| Operating profit | -12 | -15 | -18 | -28 | -36 | -57 | -51 | -73 |
| Operating margin | — | — | — | — | — | — | — | −6048.8% |
| Other income | 3 | 3 | 4 | 4 | 7 | 15 | — | 22 |
| Profit before tax | -10 | -12 | -14 | -24 | -29 | -43 | -30 | -52 |
| Tax rate | −2.3% | −2.4% | 31.0% | −1.8% | −1.8% | 2.5% | −10.6% | 6.1% |
| Net profit | -10 | -10 | -10 | -25 | -30 | -41 | -33 | -49 |
| EPS ($ per share) | -0.08 | — | -0.07 | -0.18 | -0.20 | — | -0.19 | -0.28 |
| Line item | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Equity capital | — | — | 0 | 0 | 0 |
| Reserves | -13 | -14 | -61 | -135 | -241 |
| Total liabilities | 18 | 19 | 49 | 31 | 52 |
| Fixed assets | — | — | 1 | 1 | 42 |
| Total assets | 505 | 510 | 15 | 282 | 1,528 |
| Line item | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Cash from operations | -2 | -1 | -16 | -38 | -82 |
| Cash from investing | -500 | 1 | -0 | -176 | -490 |
| Cash from financing | 505 | — | 16 | 301 | 1,263 |
| Net cash flow | 3 | 0 | 0 | 87 | 691 |
| Capital expenditure | — | — | -0 | -0 | -33 |
| Free cash flow | — | — | -16 | -39 | -115 |
Insider filings
332 filings between Nov 18, 2025 and Oct 9, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$481.22M
257 sales by 10 insiders
75% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 57
- Option exercise — converted options into shares
- 1
- Tax withheld — shares kept back by the company to cover tax
Also filed: 10 other filings, 7 gifts.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Cochran Caroline | — | $226.93M | Oct 1, 2026 |
| DeWitte Jacob | — | $226.93M | Oct 1, 2026 |
| Bealmear Richard Craig | — | $21.99M | Oct 1, 2026 |
| Goodwin William Carroll Murphy | — | $3.63M | Sep 28, 2026 |
| Jansen John M | — | $774.0K | Sep 14, 2026 |
| Schweiger Patrick Joseph | — | $314.1K | Mar 25, 2026 |
| Narayanadas Vivek | — | $232.9K | Oct 9, 2026 |
| Kinzley Richard | — | $208.4K | Mar 27, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 9, 2026 | Narayanadas Vivek General Counsel & Secretary | Sale 10b5-1 plan | 364 | $12.6K |
| Oct 8, 2026 | Narayanadas Vivek General Counsel & Secretary | Option exercise 10b5-1 plan | 687 | — |
| Oct 6, 2026 | Narayanadas Vivek General Counsel & Secretary | Sale 10b5-1 plan | 288 | $10.7K |
| Oct 5, 2026 | Narayanadas Vivek General Counsel & Secretary | Sale | 649 | $23.3K |
| Oct 3, 2026 | Narayanadas Vivek General Counsel & Secretary | Option exercise | 1,014 | — |
| Oct 2, 2026 | Bealmear Richard Craig Chief Financial Officer | Option exercise 10b5-1 plan | 5,619 | $17.9K |
| Oct 1, 2026 | Bealmear Richard Craig Chief Financial Officer | Option exercise 10b5-1 plan | 16,477 | $52.4K |
| Oct 1, 2026 | Cochran Caroline Co-Founder, COO | Sale 10b5-1 plan | 20,000 | $741.4K |
| Oct 1, 2026 | DeWitte Jacob Co-Founder, CEO | Sale 10b5-1 plan | 20,000 | $726.8K |
| Oct 1, 2026 | DeWitte Jacob Co-Founder, CEO | Sale 10b5-1 plan | 20,000 | $741.4K |
| Oct 1, 2026 | Cochran Caroline Co-Founder, COO | Sale 10b5-1 plan | 20,000 | $726.8K |
| Oct 1, 2026 | Bealmear Richard Craig Chief Financial Officer | Sale 10b5-1 plan | 16,477 | $607.5K |
| Oct 1, 2026 | DeWitte Jacob Co-Founder, CEO | Sale 10b5-1 plan | 40,000 | $1.45M |
| Oct 1, 2026 | DeWitte Jacob Co-Founder, CEO | Sale 10b5-1 plan | 40,000 | $1.47M |
| Oct 1, 2026 | Cochran Caroline Co-Founder, COO | Sale 10b5-1 plan | 40,000 | $1.47M |
| Oct 1, 2026 | Cochran Caroline Co-Founder, COO | Sale 10b5-1 plan | 40,000 | $1.45M |
| Sep 28, 2026 | Renner Alexandra Chief Product Officer | Sale | 1,100 | $41.1K |
| Sep 28, 2026 | Goodwin William Carroll Murphy Chief Strategy Officer | Sale | 1,775 | $66.4K |
| Sep 28, 2026 | Hanson John Chief of Staff | Sale | 1,100 | $41.1K |
| Sep 26, 2026 | Goodwin William Carroll Murphy Chief Strategy Officer | Option exercise | 3,294 | — |
| Sep 26, 2026 | Hanson John Chief of Staff | Option exercise | 2,059 | — |
| Sep 26, 2026 | Renner Alexandra Chief Product Officer | Option exercise | 2,471 | — |
| Sep 14, 2026 | Renner Alexandra Chief Product Officer | Gift | 6,763 | — |
| Sep 14, 2026 | Jansen John M Director | Sale | 6,354 | $233.0K |
| Sep 13, 2026 | Hanson John Chief of Staff | Option exercise | 961 | — |
| Sep 13, 2026 | Renner Alexandra Chief Product Officer | Option exercise | 1,202 | — |
| Sep 11, 2026 | Narayanadas Vivek General Counsel & Secretary | Option exercise | 210 | — |
| Sep 9, 2026 | Narayanadas Vivek General Counsel & Secretary | Sale 10b5-1 plan | 365 | $15.8K |
| Sep 8, 2026 | Narayanadas Vivek General Counsel & Secretary | Sale 10b5-1 plan | 238 | $10.0K |
| Sep 8, 2026 | Narayanadas Vivek General Counsel & Secretary | Option exercise 10b5-1 plan | 687 | — |
| Sep 4, 2026 | Narayanadas Vivek General Counsel & Secretary | Sale 10b5-1 plan | 538 | $21.5K |
| Sep 3, 2026 | Narayanadas Vivek General Counsel & Secretary | Option exercise 10b5-1 plan | 1,014 | — |
| Sep 2, 2026 | Bealmear Richard Craig Chief Financial Officer | Option exercise 10b5-1 plan | 5,666 | $18.0K |
| Sep 1, 2026 | Bealmear Richard Craig Chief Financial Officer | Option exercise 10b5-1 plan | 16,430 | $52.2K |
| Sep 1, 2026 | Bealmear Richard Craig Chief Financial Officer | Sale 10b5-1 plan | 16,430 | $636.8K |
| Sep 1, 2026 | Renner Alexandra Chief Product Officer | Sale | 1,930 | $74.1K |
| Sep 1, 2026 | DeWitte Jacob Co-Founder, CEO | Sale | 40,000 | $1.54M |
| Sep 1, 2026 | DeWitte Jacob Co-Founder, CEO | Sale | 20,000 | $771.2K |
| Sep 1, 2026 | DeWitte Jacob Co-Founder, CEO | Sale | 40,000 | $1.55M |
| Sep 1, 2026 | Cochran Caroline Co-Founder, COO | Sale | 40,000 | $1.55M |
| Sep 1, 2026 | Cochran Caroline Co-Founder, COO | Sale | 19,800 | $769.8K |
| Sep 1, 2026 | DeWitte Jacob Co-Founder, CEO | Sale | 200 | $7.8K |
| Sep 1, 2026 | Cochran Caroline Co-Founder, COO | Sale | 200 | $7.8K |
| Sep 1, 2026 | Cochran Caroline Co-Founder, COO | Sale | 40,000 | $1.54M |
| Sep 1, 2026 | DeWitte Jacob Co-Founder, CEO | Sale | 19,800 | $769.8K |
| Sep 1, 2026 | Cochran Caroline Co-Founder, COO | Sale | 20,000 | $771.2K |
| Aug 31, 2026 | Renner Alexandra Chief Product Officer | Option exercise | 4,173 | — |
| Aug 25, 2026 | Narayanadas Vivek General Counsel & Secretary | Sale 10b5-1 plan | 223 | $9.1K |
| Aug 24, 2026 | Narayanadas Vivek General Counsel & Secretary | Sale 10b5-1 plan | 3,264 | $129.8K |
| Aug 24, 2026 | Renner Alexandra Chief Product Officer | Sale | 557 | $22.2K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Oklo Inc.
Free account. Everything above stays public.
Write why you follow Oklo Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading